Clinical Trial Update: Regulation of Mucosal Immune Response to Systemic MenB Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating regulation of mucosal immune response to a systemic meningococcal B vaccine; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infections

Drugs mentioned

• MenB vaccine (Meningococcal group B vaccine)

Snippet

Sponsor: University Hospitals Bristol and Weston NHS Foundation Trust | Conditions: Meningococcal Infections | Phase 2 | Status: COMPLETED